Search results for "Cannabinoid"

showing 10 items of 323 documents

Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis

2013

Type-1 cannabinoid receptors (CB1R) are important regulators of the neurodegenerative damage in multiple sclerosis (MS) and in experimental autoimmune encephalomyelitis (EAE). In GABAergic striatal neurons, CB1R stimulation exerts protective effects by limiting inflammation-induced potentiation of glutamate-mediated spontaneous excitatory postsynaptic currents (sEPSCs). Here we show that CB1R located on GABAergic or on glutamatergic neurons are differentially involved in the pre- and postsynaptic alterations of sEPSCs caused by EAE in the striatum. After induction of EAE, mice selectively lacking CB1R on GABAergic neurons (GABA-CB1R-KO) showed exacerbated alterations of sEPSC duration in GA…

Encephalomyelitis Autoimmune ExperimentalTime FactorsPostsynaptic CurrentPresynaptic TerminalsExcitotoxicityGlutamic AcidIn Vitro TechniquesBiologyMedium spiny neuronmedicine.disease_causeSynaptic TransmissionMiceCellular and Molecular NeuroscienceGlutamatergicReceptor Cannabinoid CB1Postsynaptic potentialmedicineAnimalsgamma-Aminobutyric AcidMice KnockoutNeuronsPharmacologyExperimental autoimmune encephalomyelitisGlutamate receptorExcitatory Postsynaptic Potentialsmedicine.diseaseCorpus StriatumMice Inbred C57BLnervous systemDisease ProgressionExcitatory postsynaptic potentialFemaleSettore MED/26 - NeurologiaNeuroscience
researchProduct

ENDOCANNABINOIDS CB1 AND CB2: A POSSIBLE ROLE IN ORAL SQUAMOUS CELL CARCINOMA PATHOGENESIS

2014

Aim. Cancer of the oral cavity is the eighth most common malignancy in the world. The disease is diagnosed after a considerable delay and predict the individual progression is difficult. The improvements of the therapy did not increased the rate of survival at 5 years, that is still about 50%. The identification of the possible markers that indicates the progression of the tumor is therefore necessary. Endocannabinoids may play an important role in the process of carcinogenesis in the oral mucosa. They are able to bind and activate specific membrane receptors coupled to G proteins, cannabinoid receptors CB1 and CB2. The purpose of this study is to evaluate the expression of CB1 and CB2 rece…

Endocannabinoids OSCC
researchProduct

Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling

2012

The myenteric and submucosal plexuses of the enteric nervous system (ENS) exist as interconnected integrative nerve networks within the wall of the gastrointestinal (GI) tract. Activity of the ENS is responsible for the control of the digestive and protective functions of the gut.1 Synaptic transmission between enteric neurons propagates information from intrinsic afferent neurons to interneurons, and then from interneurons to motor neurons that control final effectors such as smooth muscle and the secretory epithelium. Acetylcholine (ACh) is the major excitatory neurotransmitter in the myenteric plexus, acting on nicotinic receptors at synapses between neurons and on muscarinic receptors a…

Endocrine and Autonomic SystemsPhysiologyGastroenterologyBiologyNeurotransmissionInhibitory postsynaptic potentialEndocannabinoid systemSynapsechemistry.chemical_compoundnervous systemchemistryMetaplasticityEnteric nervous systemNeurotransmitterNeuroscienceMyenteric plexusNeurogastroenterology & Motility
researchProduct

SY26-2ACETALDEHYDE ENDOCANNABINOIDS AND DOPAMINE: IS THIS –JUST- “A MENAGE A TROIS”?

2015

As ethanol, its first metabolite, acetaldehyde (ACD), enhances dopamine neurotransmission and exerts rewarding and motivational effects in animal models tailored for studying addictive-like behaviours. The endocannabinoid system fine-tuning dopamine cell activity, affects distinct drug-related behaviours and specific drug-induced effects. In light of this, it becomes urgent to investigate the implications of …

EthanolDopamine neurotransmissionMetaboliteAcetaldehydeendocannabinoidGeneral MedicinePharmacologyBiologyEndocannabinoid systemCell activitychemistry.chemical_compoundchemistryDopamineSettore BIO/14 - FarmacologiamedicinedopamineNeuroscienceacetaldehydemedicine.drugAlcohol and Alcoholism
researchProduct

Cannabinoids in the management of spasticity associated with multiple sclerosis.

2008

Anna Maria Malfitano, Maria Chiara Proto, Maurizio BifulcoDipartimento di Scienze Farmaceutiche, Università degli Studi di SalernoAbstract: The endocannabinoid system and cannabinoid-based treatments have been involved in a wide number of diseases. In particular, several studies suggest that cannabinoids and endocannabinoids may have a key role in the pathogenesis and therapy of multiple sclerosis (MS). In this study we highlight the main findings reported in literature about the relevance of cannabinoid drugs in the management and treatment of MS. An increasing body of evidence suggests that cannabinoids have beneficial effects on the symptoms of MS, including spasticity and pai…

Experimental allergicbusiness.industryMultiple sclerosisEncephalomyelitismedicine.medical_treatmentspasticityNeurosciences. Biological psychiatry. NeuropsychiatryReviewPharmacologymedicine.diseasemultiple sclerosisEndocannabinoid systemPsychiatry and Mental healthcannabinoidsmedicinelipids (amino acids peptides and proteins)Neurology. Diseases of the nervous systemCannabinoidSpasticitymedicine.symptomRC346-429businessBeneficial effectsBiological PsychiatryRC321-571Neuropsychiatric disease and treatment
researchProduct

Requirement of cannabinoid CB1 receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections

2010

A role for endocannabinoid signaling in neuronal morphogenesis as the brain develops has recently been suggested. Here we used the developing somatosensory circuit as a model system to examine the role of endocannabinoid signaling in neural circuit formation. We first show that a deficiency in cannabinoid receptor type 1 (CB(1)R), but not G-protein-coupled receptor 55 (GPR55), leads to aberrant fasciculation and pathfinding in both corticothalamic and thalamocortical axons despite normal target recognition. Next, we localized CB(1)R expression to developing corticothalamic projections and found little if any expression in thalamocortical axons, using a newly established reporter mouse expre…

General Neurosciencemedicine.medical_treatmentThalamusBiologySomatosensory systemEndocannabinoid systemCortex (botany)medicine.anatomical_structurenervous systemGPR55Cerebral cortexCannabinoid receptor type 1medicineCannabinoidNeuroscienceEuropean Journal of Neuroscience
researchProduct

Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice.

2007

The endocannabinoid system (ECS) possesses neuromodulatory functions by influencing the release of various neurotransmitters, including GABA, noradrenaline, dopamine, glutamate and acetylcholine. Even though there are studies indicating similar interactions between the ECS and the serotonergic system, there are no results showing clear evidence for type 1 cannabinoid receptor (CB1) location on serotonergic neurons. In this study, we show by in situ hybridization that a low but significant fraction of serotonergic neurons in the raphe nuclei of mice contains CB1 mRNA as illustrated by the coexpression with the serotonergic marker gene tryptophane hydroxylase 2, the rate limiting enzyme for t…

Genetic MarkersSerotoninSerotonin uptakeBiologyTryptophan HydroxylaseSerotonergicHippocampuschemistry.chemical_compoundMiceNerve FibersReceptor Cannabinoid CB1Cannabinoid receptor type 1AnimalsRNA MessengerNeurotransmitterIn Situ HybridizationSerotonin Plasma Membrane Transport ProteinsMicroscopy ConfocalTPH2General NeuroscienceAmygdalaEndocannabinoid systemImmunohistochemistryIsoenzymesMice Inbred C57BLnervous systemchemistryDentate GyrusSynapsesRaphe NucleiFemaleSerotoninRaphe nucleiNeuroscienceNeuroscience
researchProduct

Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology

2014

Genetic dissectionmedicine.medical_treatmentmedicineCannabinoidBiologyPharmacologyEndocannabinoid systemNeuroscience
researchProduct

Mechanisms of gustatory perception of dietary lipids : cross-talk with bitter taste and endocannabinoid receptors

2018

Obesity is one of the major public health problems at the beginning of the 21st century. Its prevalence is increasing steadily, especially among children. This observation is not insignificant because obesity is generally associated with various serious pathologies (type 2 diabetes, hypertension and cancer, etc.). Thus, investigations into the mechanisms involved in the taste perception of dietary lipids could shed light on their roles in the incidence of obesity.Several studies have demonstrated the role of endocannabinoids and bitter foods in obesity. Thus, we studied the cross-talk of cannabinoid receptors and bitter taste with lipid taste. This thesis has two components: cannabinoid rec…

Goût de grasTaste cells[SDV.AEN] Life Sciences [q-bio]/Food and NutritionHtc-8AmerCellules gustativesEndocannabinoïdes[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Cb1rBitter tasteFat tasteEndocannabinoids
researchProduct

Sensitive Screening of New Psychoactive Substances in Serum Using Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry.

2021

Abstract Analysis of new psychoactive substances (NPS) still poses a challenge for many institutions due to the number of available substances and the constantly changing drug market. Both new and well-known substances keep appearing and disappearing on the market, making it hard to adapt analytical methods in a timely manner. In this study we developed a qualitative screening approach for serum samples by means of liquid chromatography--quadrupole time-of-flight mass spectrometry. Samples were measured in data-dependent auto tandem mass spectrometry mode and identified by fragment spectra comparison, retention time and accurate mass. Approximately 500 NPS, including 195 synthetic cannabino…

Health Toxicology and MutagenesisToxicologyMass spectrometry01 natural sciencesMethcathinoneAnalytical Chemistry03 medical and health sciencesBenzodiazepines0302 clinical medicineTandem Mass SpectrometrySynthetic cannabinoidsmedicineEnvironmental Chemistry030216 legal & forensic medicineSolid phase extractionQuadrupole time of flightPsychotropic DrugsChemical Health and SafetyChromatographyChemistryElution010401 analytical chemistryReproducibility of ResultsSerum samples0104 chemical sciencesSubstance Abuse DetectionRetention timemedicine.drugChromatography LiquidJournal of analytical toxicology
researchProduct